{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:37:11Z","timestamp":1793277431295,"version":"4.5.0"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,29]]},"DOI":"10.1093\/ehjacc\/zuag124","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:32:43Z","timestamp":1792423963000},"page":"739-740","source":"Crossref","is-referenced-by-count":0,"title":["Inflammation in cardiogenic shock: a marker of outcome, not yet a treatment target"],"prefix":"10.1093","volume":"15","author":[{"given":"Tomasz J","family":"Guzik","sequence":"first","affiliation":[{"name":"Centre for Cardiovascular Sciences, University of Edinburgh , Edinburgh EH16 4TJ ,","place":["UK"]},{"name":"National Heart and Lung Institute, Imperial College London , London W12 0NN ,","place":["UK"]},{"name":"Department of Internal Medicine, Jagiellonian University Collegium Medicum , Krakow Military Hospital, ul. Wroc\u0142awska 1-3, Krak\u00f3w 31-130 ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"key":"2026102908173994300_zuag124-B1","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","article-title":"SCAI SHOCK stage classification expert consensus update: a review and incorporation of validation studies: this statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021","volume":"79","author":"Naidu","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026102908173994300_zuag124-B2","article-title":"Associations between admission C-reactive protein and in-hospital mortality amongst patients with cardiogenic shock","author":"Mendelsohn","year":"2026","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026102908173994300_zuag124-B3","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00392-023-02336-8","article-title":"Association of systemic inflammation with shock severity, 30-day mortality, and therapy response in patients with cardiogenic shock","volume":"113","author":"Dettling","year":"2024","journal-title":"Clin Res Cardiol"},{"key":"2026102908173994300_zuag124-B4","first-page":"59","article-title":"C-reactive protein levels and outcomes in infarct-related cardiogenic shock: data from the ECLS-SHOCK trial","volume":"14","author":"Schupp","year":"2025","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026102908173994300_zuag124-B5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.006956","article-title":"Systemic inflammatory response syndrome is associated with increased mortality across the spectrum of shock severity in cardiac intensive care patients","volume":"13","author":"Jentzer","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026102908173994300_zuag124-B6","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"2026102908173994300_zuag124-B7","author":"Novo Nordisk"},{"key":"2026102908173994300_zuag124-B8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa2405922","article-title":"Colchicine in acute myocardial infarction","volume":"392","author":"Jolly","year":"2025","journal-title":"N Engl J Med"},{"key":"2026102908173994300_zuag124-B9","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1016\/j.jacc.2026.01.019","article-title":"Effect of tocilizumab on pro-B-type natriuretic peptide and infarct size in patients with acute myocardial infarction at risk of cardiogenic shock (DOBERMANN-T)","volume":"87","author":"Kunkel","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"2026102908173994300_zuag124-B10","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction","volume":"77","author":"Broch","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026102908173994300_zuag124-B11","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1093\/eurheartj\/ehab110","article-title":"The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction","volume":"42","author":"Ceglarek","year":"2021","journal-title":"Eur Heart J"},{"key":"2026102908173994300_zuag124-B12","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/cvr\/cvae224","article-title":"Interleukin 11 therapy causes acute left ventricular dysfunction","volume":"120","author":"Sweeney","year":"2024","journal-title":"Cardiovasc Res"}],"container-title":["European Heart Journal: Acute Cardiovascular Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjacc\/advance-article-pdf\/doi\/10.1093\/ehjacc\/zuag124\/72115203\/zuag124.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjacc\/article-pdf\/15\/10\/739\/72115203\/zuag124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjacc\/article-pdf\/15\/10\/739\/72115203\/zuag124.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:17:43Z","timestamp":1793276263000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjacc\/article\/15\/10\/739\/8943577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":12,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,19]]},"published-print":{"date-parts":[[2026,10,29]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjacc\/zuag124","relation":{},"ISSN":["2048-8726","2048-8734"],"issn-type":[{"value":"2048-8726","type":"print"},{"value":"2048-8734","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,10]]}}}